Information Technology · Services-Business Services, NEC

CTEV Claritev Corp SEC Filings & Insider Trading Activity 2026

company
CIK 1793229100 filings
Russell 2000

CTEV at a glance

Claritev Corp (CTEV, SEC CIK 1793229) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Claritev Corp (CTEV) reported revenue of $965.4 million (up 3.7% from FY2024) and a net loss of $284.3 million. Diluted EPS was -$17.30.
  • As of September 30, 2026, 23 institutional investment managers tracked by SignalX reported holding Claritev Corp (CTEV) shares worth $70.0 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Klein Michael Stuart on November 12, 2026 of 20,067 shares at $27.07 per share.
  • In the last 90 days, CTEV insiders reported 13 open-market purchases ($10.4M) and 6 open-market sales ($2.2M) on Form 4, a net purchase of $8.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$965.4M
+3.7% vs prior year
Insiders · 90 days
13 buys · 6 sells
Net +$8.2M
13F holders
23 funds
$70.0M · +1 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • DOJ civil investigative demand received May 19, 2026, with inquiry ongoing after separate antitrust proceeding closure
  • Regulatory risk: evolving healthcare laws may increase litigation exposure for cost management providers
  • Legal risk: provider and member litigation increasingly multi-party, multi-claim, or class-wide
  • Financial risk: uninsured or insufficiently insured litigation losses could materially affect results

Management Discussion & Analysis

  • Revenue $268.3M, up 9.1% YoY from $246.0M
  • Operating margin 7.7% vs 4.1% YoY, net loss $61.8M vs $69.8M
  • Best segment: Claims intelligence revenue $192.5M, up 17.1%; worst: Payment and revenue integrity $25.9M, down 9.8%
  • Cash balance $23.0M, operating cash flow $65.0M, investing outflow $128.8M
  • Outlook: liquidity sufficient for next twelve months, with technology investments and antitrust legal expenses as headwinds

AI summary of the CTEV 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results for the quarter ended September 30, 2026 announced on November 9, 2026
  • Detailed financial results and management commentary available in Exhibit 99.1, the earnings press release

Item EX-99.1: Item EX-99.1

  • Q3 revenue $268.3M, up 9.1%, signaling continued growth across Claritev’s healthcare technology offerings
  • Net loss narrowed to $61.8M from $69.8M, but interest expense remained substantial at $100.9M
Filed Oct 15, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Board expanded from 11 to 12 directors, increasing governance capacity
  • Jennifer Main appointed Class II director effective October 15, 2026

Item 7.01: Regulation FD Disclosure

  • Claritev appointed Ms. Main to its Board of Directors
  • Appointment signals a board-composition change, potentially affecting governance and strategic oversight
Filed Sep 15, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Ben Letham appointed Class I director effective September 14, 2026, filling vacancy after John Prince’s passing
  • Risk Committee appointment adds oversight responsibility

Item 7.01: Regulation FD Disclosure

  • Claritev appointed Mr. Letham to its Board, adding a new director to corporate oversight
  • Board appointment may affect governance, strategic direction and shareholder representation

AI summaries of CTEV 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for CTEV

Don't miss the next CTEV filing

  • Alerts as it files. A push when CTEV files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut CTEV, by share count.
  • Ask anything. An AI agent that reads every CTEV filing and answers with sources.

CTEV alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Klein Michael StuartSellNov 12, 2026$27.07
ARES MANAGEMENT LLCBuyNov 11, 2026$28.73
ARES MANAGEMENT LLCBuyNov 11, 2026$28.73
Dalton TravisBuyNov 11, 2026$29.34
Klein Michael StuartSellNov 11, 2026$28.60
Klein Michael StuartSellNov 10, 2026$23.75
ARES MANAGEMENT LLCBuyNov 10, 2026$26.14
ARES MANAGEMENT LLCBuyNov 10, 2026$26.14

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$930.6M$965.4M
Operating Income$162.0M-$1.4B$28.8M
Net Income--$1.6B-$284.3M
Op. Margin--149.4%3.0%
Net Margin--176.9%-29.4%
Balance Sheet
Total Assets$7.0B$5.2B$4.9B
Equity-$84.0M-$173.9M
ROE--1958.8%163.5%
Per Share
EPS$-0.14$-101.92$-17.30
Cash Flow
Operating CF-$107.6M$117.3M
CapEx$108.9M$118.1M$129.6M

Source: XBRL data in Claritev Corp (CTEV)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate CTEV share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
CTEV shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202623$70.0M
Q2 202622$80.9M
Q1 202622$34.7M
Q4 202524$108.2M
Q3 202520$113.6M
Q2 202522$90.0M
Q1 202517$23.8M
Q4 202410$14.5M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 160 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

CTEV filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 16, 2026--
4Nov 16, 2026--
4Nov 13, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
4Oct 27, 2026--
4Oct 27, 2026--
4Oct 19, 2026--
4Oct 16, 2026--
8-KOct 15, 2026Analysis-
4Sep 22, 2026--
4Sep 16, 2026--
8-KSep 15, 2026Analysis-
4Aug 31, 2026--
4Aug 18, 2026--
4Aug 12, 2026--
4Aug 7, 2026--
8-KAug 7, 2026Analysis-
4Aug 7, 2026--
10-QAug 7, 2026Analysis
8-KJul 6, 2026Analysis-
4Jul 2, 2026--

Related Information Technology companies

All Information Technology →

CTEV SEC filings: frequently asked questions

Are CTEV insiders buying or selling?

In the last 90 days, Claritev Corp (CTEV) officers, directors and 10% owners reported 13 open-market purchases worth $10.4 million by 2 insiders and 6 open-market sales worth $2.2 million by 3 insiders on Form 4, a net purchase of $8.2 million. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold CTEV stock?

As of September 30, 2026, the largest Claritev Corp (CTEV) holders among the 13F filers tracked by SignalX were BlackRock ($16.4 million), Vanguard Capital Management LLC ($12.4 million), Prudential Financial ($8.0 million), JPMorgan Chase & Co ($7.7 million), AQR Capital Management ($3.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was CTEV's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Claritev Corp (CTEV) reported revenue of $965.4 million (up 3.7% from FY2024) and a net loss of $284.3 million. Diluted EPS was -$17.30. The figures come from the XBRL data in the 10-K.

What did CTEV report in its latest 8-K?

Claritev Corp (CTEV) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 2026 results for the quarter ended September 30, 2026 announced on November 9, 2026.

What are the latest CTEV SEC filings?

Claritev Corp (CTEV) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 16, 2026.

What is CTEV's SEC CIK number?

Claritev Corp (CTEV)'s SEC Central Index Key (CIK) is 1793229. EDGAR lists every CTEV filing under that number.

Ask anything about CTEV

The research agent reads CTEV's filings, financials, insider trades and 13F holders, then answers with sources.